Takeda Pharmaceutical Company Limited
HETEROCYCLIC COMPOUND

Abstract:

Provided is a compound that may have a superior CDK12 inhibitory action and is expected to be useful as a prophylactic or therapeutic drug for cancer and the like. A compound represented by the following formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof.